Health services researcher at Vanderbilt Health Policy. Avid coffee drinker, investigator of drug policies & prices. RT not an endorsement. Opinions are mine.
Hunter syndrome: Boy with rare condition amazes doctors after world-first gene therapy share.google/POY4UXyNcBUL...
Reposted by Stacie B. Dusetzina, Nathan P. Kalmoe
www.insidehighered.com/news/governa...
Reposted by Stacie B. Dusetzina
www.mskcc.org/news/msk-res...
@dusetzinas.bsky.social
Reposted by Stacie B. Dusetzina, Christian E. Weller, David Darmofal
Republicans have tried to kill the ACA more than 70 times since 2010, and have never once had a plan for anything better.
Reposted by Stacie B. Dusetzina
Reposted by Stacie B. Dusetzina
Reposted by Stacie B. Dusetzina
Reposted by Stacie B. Dusetzina
www.science.org/content/arti...
Reposted by Stacie B. Dusetzina, Dana Howard
Guess what roundtables don't have? FACA requirements to occur in public with the opportunity for public comment.
We looked at trends in biologic drug prices after biosimilar competition.
Key takeaways: savings from biosimilars are substantial, but take longer to accrue than commonly seen with generic small molecules.
1/
jamanetwork.com/journals/jam...
Reposted by Stacie B. Dusetzina
We looked at trends in biologic drug prices after biosimilar competition.
Key takeaways: savings from biosimilars are substantial, but take longer to accrue than commonly seen with generic small molecules.
1/
jamanetwork.com/journals/jam...
Reposted by Stacie B. Dusetzina
Reposted by Stacie B. Dusetzina, Julie Novkov, Olúfẹ́mi Táíwò
“We started in a little room. Great things start in little rooms”
Reposted by Jason Mittell, Michael Barnett, Michael S. Rosenberg , and 30 more Jason Mittell, Michael Barnett, Michael S. Rosenberg, Jesse M. Shapiro, Delphine K. Farmer, Joshua S. Weitz, John R. Hutchinson, Scott L. Greer, Stacie B. Dusetzina, Steven French, Megan L. Ranney, Rosemary A. Joyce, Mark E. Schaffer, Amir Attaran, Dawn J. Wright, Paul E. Smaldino, Kevin Carey, Bonnie Honig, Smith, Rebecca Tushnet, Michael W. Kraus, David Merrett, W. Andy Knight, Paul Goldsmith-Pinkham, Brian Keegan, Sarah Roberts, Lisa Diedrich, Ann Bartow, Catherine J. Frieman, Michael Larkin, Aviel Roshwald, Carly D. Ziter, Shan Kothari
Upon hearing the news James Watson had died, a STAT reporter said in our Slack, "I wish I could read what Sharon would have written."
Incredible news: Sharon in fact did pre-write a Watson obit. And it is masterful and excoriating.
🧪🧬🧫
Reposted by Stacie B. Dusetzina, American Library Association
Reposted by Stacie B. Dusetzina, Dan Immergluck
It has burdened low-income borrowers while generating huge profits for lenders.
(Published May with @tennesseelookout.com)
Reposted by Stacie B. Dusetzina
Reposted by Stacie B. Dusetzina
Reposted by Kathryn A. Phillips
www.pbs.org/newshour/sho...
Reposted by Stacie B. Dusetzina
Reposted by Stacie B. Dusetzina, Patrick Stokes
Reposted by Stacie B. Dusetzina
Reposted by Cary P. Gross, Stacie B. Dusetzina
We studied whether oncologists tend to use cancer treatments that are more beneficial, more profitable, or both.
I was surprised by the results: clinical benefit mattered, profit did not.
1/
cc: @dusetzinas.bsky.social
www.bmj.com/content/391/...